Atyr Pharma Inc Stock Ownership - Who owns Atyr Pharma?

Insider buying vs selling

Have Atyr Pharma Inc insiders been buying or selling?
Nancy DenyesGeneral Counsel2024-06-055,000$1.86
Sanjay ShuklaPresident and CEO2024-05-3120,000$1.81
Jill Marie BroadfootChief Financial Officer2024-05-315,000$1.79
Timothy CoughlinDirector2024-05-3050,000$1.75
Jill Marie BroadfootChief Financial Officer2024-02-061,590$1.69
Sanjay ShuklaPresident and CEO2023-12-1212,000$1.18
Sanjay ShuklaPresident and CEO2023-12-113,000$1.17
Sanjay ShuklaPresident and CEO2023-11-1313,578$1.11
Sanjay ShuklaPresident and CEO2023-11-101,422$1.14
Sanjay ShuklaPresident and CEO2023-07-2815,000$2.02

1 of 1

ATYR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATYR insiders and whales buy or sell their stock.

ATYR Shareholders

What type of owners hold Atyr Pharma Inc stock?
Federated Hermes Inc14.74%10,169,600$18.81MInstitution
Fmr LLC12.93%8,923,210$16.51MInstitution
Logos Global Management LP4.49%3,100,000$5.74MInstitution
Vanguard Group Inc3.84%2,652,157$4.91MInstitution
Tikvah Management LLC3.57%2,460,833$4.55MInstitution
Citadel Advisors LLC2.76%1,903,346$3.52MInstitution
Sofinnova Venture Partners Ix LP2.70%1,866,126$3.45MInsider
Srinivas Akkaraju2.70%1,866,126$3.45MInsider
Amir Nashat2.67%1,840,564$3.41MInsider
Polaris Venture Management Co V LLC2.65%1,827,992$3.38MInsider

1 of 3

ATYR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATYR60.58%22.26%Net BuyingNet Buying
CRVS28.60%47.75%Net BuyingNet Buying
NVCT8.51%49.77%Net BuyingNet Buying

Atyr Pharma Stock Ownership FAQ

Who owns Atyr Pharma?

Atyr Pharma (NASDAQ: ATYR) is owned by 60.58% institutional shareholders, 22.26% Atyr Pharma insiders, and 17.16% retail investors. Sofinnova Venture Partners Ix LP is the largest individual Atyr Pharma shareholder, owning 1.87M shares representing 2.70% of the company. Sofinnova Venture Partners Ix LP's Atyr Pharma shares are currently valued at $3.42M.

If you're new to stock investing, here's how to buy Atyr Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.